Michelle A. Lowes

17.5k total citations · 8 hit papers
113 papers, 12.4k citations indexed

About

Michelle A. Lowes is a scholar working on Dermatology, Immunology and Surgery. According to data from OpenAlex, Michelle A. Lowes has authored 113 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Dermatology, 57 papers in Immunology and 37 papers in Surgery. Recurrent topics in Michelle A. Lowes's work include Hidradenitis Suppurativa and Treatments (48 papers), Psoriasis: Treatment and Pathogenesis (39 papers) and Colorectal and Anal Carcinomas (36 papers). Michelle A. Lowes is often cited by papers focused on Hidradenitis Suppurativa and Treatments (48 papers), Psoriasis: Treatment and Pathogenesis (39 papers) and Colorectal and Anal Carcinomas (36 papers). Michelle A. Lowes collaborates with scholars based in United States, Canada and Australia. Michelle A. Lowes's co-authors include James G. Krueger, Mayte Suárez‐Fariñas, Lisa C. Zaba, Judilyn Fuentes‐Duculan, A. Bowcock, Irma Cardinale, Inna Novitskaya, Artemis Khatcherian, Asifa Haider and Katherine C. Pierson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Michelle A. Lowes

111 papers receiving 12.1k citations

Hit Papers

Pathogenesis and therapy ... 2005 2026 2012 2019 2007 2014 2008 2008 2007 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pathogenesis and therapy of psoriasis
    2007 1.4k citations Michelle A. Lowes, James G. Krueger et al. profile →
  2. Immunology of Psoriasis
    2014 1.2k citations Michelle A. Lowes, Mayte Suárez‐Fariñas et al. profile →
  3. Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
    2008 855 citations Michelle A. Lowes, Judilyn Fuentes‐Duculan et al. Journal of Investigative Dermatology profile →
  4. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways
    2008 665 citations Lisa C. Zaba, Emma Guttman‐Yassky et al. British Journal of Dermatology profile →
  5. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses
    2007 540 citations Lisa C. Zaba, Irma Cardinale et al. profile →
  6. Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)
    2005 373 citations Michelle A. Lowes, Francesca Chamian et al. profile →
  7. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
    2019 224 citations Ali Alikhan, Christopher J. Sayed et al. Journal of the American Academy of Dermatology profile →
  8. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
    2019 222 citations Ali Alikhan, Christopher J. Sayed et al. Journal of the American Academy of Dermatology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Michelle A. Lowes 8.8k 6.3k 2.1k 1.8k 1.7k 113 12.4k
Jóhann E. Guðjónsson 9.0k 1.0× 5.3k 0.8× 1.9k 0.9× 1.8k 1.0× 3.0k 1.7× 276 13.9k
Bruce Strober 7.6k 0.9× 5.1k 0.8× 1.2k 0.6× 1.0k 0.6× 1.6k 1.0× 285 11.1k
Knud Kragballe 5.2k 0.6× 3.6k 0.6× 1.2k 0.5× 881 0.5× 2.2k 1.3× 256 9.2k
James T. Elder 5.4k 0.6× 3.0k 0.5× 1.2k 0.6× 2.1k 1.1× 4.3k 2.5× 175 11.2k
Judilyn Fuentes‐Duculan 6.4k 0.7× 5.6k 0.9× 2.2k 1.0× 1.1k 0.6× 1.0k 0.6× 70 9.8k
Sergio Chimenti 4.0k 0.5× 3.4k 0.5× 840 0.4× 1.5k 0.8× 1.0k 0.6× 187 7.2k
Errol P. Prens 3.6k 0.4× 8.0k 1.3× 887 0.4× 726 0.4× 1.1k 0.6× 219 11.2k
Antonio Costanzo 3.6k 0.4× 2.2k 0.4× 848 0.4× 3.5k 1.9× 4.6k 2.7× 288 10.7k
Kamran Ghoreschi 4.4k 0.5× 1.7k 0.3× 811 0.4× 2.0k 1.1× 1.7k 1.0× 143 8.2k
Cristina Albanesi 4.5k 0.5× 2.4k 0.4× 903 0.4× 1.5k 0.8× 1.5k 0.8× 104 7.7k

Countries citing papers authored by Michelle A. Lowes

Since Specialization
Citations

This map shows the geographic impact of Michelle A. Lowes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle A. Lowes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle A. Lowes more than expected).

Fields of papers citing papers by Michelle A. Lowes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle A. Lowes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle A. Lowes. The network helps show where Michelle A. Lowes may publish in the future.

Co-authorship network of co-authors of Michelle A. Lowes

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle A. Lowes. A scholar is included among the top collaborators of Michelle A. Lowes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle A. Lowes. Michelle A. Lowes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frew, John W., Joslyn S. Kirby, Afsáneh Alavi, et al.. (2024). Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients. Journal of the European Academy of Dermatology and Venereology. 39(1). 210–220. 1 indexed citations
2.
Lowes, Michelle A., Stephanie R. Goldberg, Afsáneh Alavi, & Haley B. Naik. (2022). Combining medical and surgical management strategies for hidradenitis suppurativa: Need for a treat to target approach. 3(3). 123–125.
3.
Tzellos, Thrasyvoulos, Kelsey R. van Straalen, Αthanassios Kyrgidis, et al.. (2022). Development and validation of IHS4‐55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology. 37(2). 395–401. 30 indexed citations
4.
Lowes, Michelle A., et al.. (2021). Clinical considerations in the management of hidradenitis suppurativa in women. International Journal of Women’s Dermatology. 7(5). 664–671. 16 indexed citations
5.
Lowes, Michelle A., et al.. (2021). Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?. American Journal of Clinical Dermatology. 22(2). 139–147. 11 indexed citations
6.
Hamzavi, Iltefat, et al.. (2021). Hidradenitis Suppurativa Specialty Clinics in the USA. Skin Appendage Disorders. 7(5). 359–362. 2 indexed citations
7.
Price, Kyla N., Tristan Grogan, Raed Alhusayen, et al.. (2021). Physician perspectives on complementary and alternative medicine in hidradenitis suppurativa. Dermatologic Therapy. 34(2). e14851–e14851. 6 indexed citations
8.
Frew, John W., Angelo Valerio Marzano, Kerstin Wolk, et al.. (2020). A Systematic Review of Promising Therapeutic Targets in Hidradenitis Suppurativa: A Critical Evaluation of Mechanistic and Clinical Relevance. Journal of Investigative Dermatology. 141(2). 316–324.e2. 52 indexed citations
9.
Narla, Shanthi, et al.. (2020). Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils. British Journal of Dermatology. 184(6). 1004–1013. 21 indexed citations
10.
Mansour, Mark, et al.. (2020). Therapeutic Drug Monitoring in Patients with Suboptimal Response to Adalimumab for Hidradenitis Suppurativa: A Retrospective Case Series. American Journal of Clinical Dermatology. 22(2). 275–283. 10 indexed citations
11.
Hendricks, Aleksi J., Jennifer L. Hsiao, Michelle A. Lowes, & Vivian Y. Shi. (2019). A Comparison of International Management Guidelines for Hidradenitis Suppurativa. Dermatology. 237(1). 81–96. 82 indexed citations
12.
Ghias, Mondana, Michael J. Hyde, Lewis E. Tomalin, et al.. (2019). Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa. Journal of Investigative Dermatology. 140(3). 531–536.e1. 27 indexed citations
13.
Alikhan, Ali, Christopher J. Sayed, Afsáneh Alavi, et al.. (2019). North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Journal of the American Academy of Dermatology. 81(1). 91–101. 222 indexed citations breakdown →
14.
Hoffman, Lauren, Lewis E. Tomalin, Gregory S. Schultz, et al.. (2018). Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature. PLoS ONE. 13(9). e0203672–e0203672. 69 indexed citations
15.
Farzanfar, Delaram, Yekta Dowlati, Lars E. French, Michelle A. Lowes, & Afsáneh Alavi. (2018). Inflammation: A Contributor to Depressive Comorbidity in Inflammatory Skin Disease. Skin Pharmacology and Physiology. 31(5). 246–251. 58 indexed citations
16.
Hoffman, Lauren, et al.. (2017). 235 Anemia in hidradenitits suppurativa. Journal of Investigative Dermatology. 137(5). S40–S40. 1 indexed citations
17.
Adams, Sylvia, Michelle A. Lowes, David O’Neill, et al.. (2008). Lack of Functionally Active Melan-A26–35-Specific T Cells in the Blood of HLA-A2+ Vitiligo Patients. Journal of Investigative Dermatology. 128(8). 1977–1980. 5 indexed citations
18.
Zaba, Lisa C., Judilyn Fuentes‐Duculan, Narat J. Eungdamrong, et al.. (2008). Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic Cells. Journal of Investigative Dermatology. 129(1). 79–88. 347 indexed citations
19.
Guttman‐Yassky, Emma, Michelle A. Lowes, Asifa Haider, et al.. (2007). Human Basal Cell Carcinoma Is Associated with Foxp3+ T cells in a Th2 Dominant Microenvironment. Journal of Investigative Dermatology. 127(10). 2391–2398. 103 indexed citations
20.
Gottlieb, Alice B., Francesca Chamian, Irma Cardinale, et al.. (2005). TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques. The Journal of Immunology. 175(4). 2721–2729. 305 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jóhann E. Guðjónsson Breakdown of academic impact, for papers by Bruce Strober Breakdown of academic impact, for papers by Knud Kragballe Breakdown of academic impact, for papers by James T. Elder Breakdown of academic impact, for papers by Judilyn Fuentes‐Duculan Breakdown of academic impact, for papers by Sergio Chimenti Breakdown of academic impact, for papers by Errol P. Prens Breakdown of academic impact, for papers by Antonio Costanzo Breakdown of academic impact, for papers by Kamran Ghoreschi Breakdown of academic impact, for papers by Cristina Albanesi
Rankless by CCL
2026